Trial Profile
A prospective non-randomized single-centre long-term comparison study to evaluate the efficacy and safety of biodegradable polymer biolimus A9-eluting stent versus durable polymer everolimus-eluting stent in diabetic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary) ; Everolimus
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 09 Dec 2015 New trial record